Results 211 to 220 of about 189,721 (306)
Conservation status of species used in the UK herbal medicine industry
Given the ongoing biodiversity crisis, sustainable use and management of medicinal plants is critical. We assessed the conservation status, threats and conservation actions of 298 species sold by UK suppliers to medical herbalists. We found that most species used are unevaluated, representing a gap in conservation knowledge, and of those with ...
Isabella Flowers +2 more
wiley +1 more source
Challenges in performing clinical research on herbal products - experiences from Switzerland and the UK. [PDF]
Bourqui A +7 more
europepmc +1 more source
This study develops a method combining radiochromic film and image processing to assess HDR brachytherapy source accuracy and linearity, achieving high precision and efficiency . Abstract Purpose To develop and validate a fully automated quality assurance method for high‐dose rate (HDR) brachytherapy, enabling the precise evaluation of source dwell ...
Qingqing Yuan +4 more
wiley +1 more source
Exploring Genome-Wide Mutation Dynamics and Bacterial Cellulose Impairment in <i>Komagataeibacter intermedius</i> Cultivated Under Agitation Stress. [PDF]
Bersanetti D, Mangayil R.
europepmc +1 more source
Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley +1 more source
The post-translational adaptor protein SadB modulates the pathogenicity of <i>Pseudomonas aeruginosa</i>. [PDF]
Papangeli M +5 more
europepmc +1 more source
Ashwagandha: Is It Safe? Part 1: A Regulatory Review
ABSTRACT Over the last decade, ashwagandha (Withania somnifera (L.) Dunal, AS) has been brought under increasing scrutiny by EU regulators regarding its safety for the use in food supplements, culminating in a recent recommendation for an Article 8 procedure according to Regulation (EC) No. 1925/2006 in the European Union (EU).
T. Brendler +5 more
wiley +1 more source
An improved fully-automated GMP radiosynthesis of [<sup>18</sup>F]fluoro-pivalic acid with solid-phase extraction purification. [PDF]
Barnes C +10 more
europepmc +1 more source

